CALL: (661) 257-8400

This Month Only:

Take $50 OFF Botox®  and $75 OFF JUVÉDERM®  Dermal FIllers!

Offer valid for procedures that take place in the month of May 2021

Fine Lines & Wrinkles

Fine lines are a result of both aging and facial movements such as squinting or smiling.

Schedule a Consultation

Best for treating:

Brown Spots & Sun Spots

Uneven Pigmentation

Fine Lines & Wrinkles

Enlarged Pores

Treatment Options for Fine Lines & Wrinkles

There are several non-invasive methods of treating fine lines depending on their cause, location, and depth.
 
The Solutions

Botox®, Dysport®, and Jeuveau®

Neuromodulators, also known as neurotoxins, immobilize the muscles that cause expression lines and wrinkles. These injectables are best used around the forehead, eyes, and upper lip. Results are not immediate and will continue to improve over the course of 0-2 weeks. Our expert team will help determine the best injectable for you and your needs.

Learn More

Dermal Fillers

Natural dermal fillers are highly effective in filling in fine lines, especially around the mouth, cheeks, and chin. Dermal fillers can take years off your appearance by restoring volume to places that have lost subcutaneous fat. These FDA-approved fillers can plump the lips, correct nasal imperfections, contour the jawline, smooth the hands, and diminish wrinkles.

Learn More

Ultherapy

Ultherapy, the only FDA-cleared ultrasound procedure to non invasively lift the eyebrow, neck, and under-chin area, is now also FDA cleared to improve décolletage lines and wrinkles! Smooth skin on the chest with micro-focused ultrasound that prompts the production of new collagen.
 
Learn More

Laser Genesis

In addition to refining pores, smoothing uneven textures, reversing sun damage, and helping with rosacea and acne, Laser Genesis also stimulates collagen production to lessen fine lines. Plus, because treatments typically take 30 minutes or less, Laser Genesis can easily be performed on a routine lunch break. Laser Genesis is most commonly used to treat the face or neck but can be used anywhere on the body.
 
Learn More

Fraxel®

Fraxel Restore is a 4-treatment series of non-invasive laser resurfacing that promotes natural skin rejuvenation and collagen production to reduce or remove fine lines. Fraxel can also be used to reduce acne scarring, diminish brown spots and treat keratosis.

Learn More

Chemical Peels

Both the VI Peel and ZO 3-Step Peel are great for targeting fine lines, discoloration, rough texture, large pores, and dullness. Peels are also a great alternative for patients with darker skin tones on which certain laser treatments cannot be safely used.
Learn More

Microneedling

We offer several medical-grade microneedling treatment options for gorgeous, youthful skin. Microneedling stimulates the production of growth factors to dramatically reduce fine lines, diminish scarring and improve skin texture.

Learn More

Dr. Ingber, M.D.

Dermacure is an aesthetic medical office owned and operated by Craig Ingber, MD a board certified Facial Plastic Surgeon.

Dr. Ingber is a clinical instructor of surgery at UCLA Medical School and performs all injections upon request. He is a top 1% injector of Botox and Juvederm in the nation and is the #1 physician injector in Santa Clarita Valley.

LEARN MORE ABOUT DR. INGBER

There are so many options for treating fine lines and wrinkles. Schedule a consultation to discuss the best option for you!

Read More

KYBELLA® (deoxycholic acid) injection 10 mg/mL Important Information

INDICATION
KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.

The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS 
KYBELLA® is contraindicated in the presence of infection at the injection sites.

WARNINGS AND PRECAUTIONS
Marginal Mandibular Nerve Injury
Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.

Dysphagia
Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.

Injection-Site Hematoma/Bruising
In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.

Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures
To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.

Injection Site Alopecia
Cases of injection site alopecia have been reported with administration of KYBELLA®. Onset and duration may vary among individuals and may persist. Consider withholding subsequent treatments until resolution.

Injection Site Ulceration and Necrosis
Injections that are too superficial into the dermis may result in skin ulceration and necrosis. Cases of injection site ulceration and necrosis have been reported with administration of KYBELLA®. Do not administer KYBELLA® into affected area until complete resolution.

ADVERSE REACTIONS
The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.

Please see KYBELLA® full Prescribing Information.

*Individual results may vary.
Call Us Today! 661-257-8400

Instantly achieve the perfect pout you've been wishing for!

Read More

KYBELLA® (deoxycholic acid) injection 10 mg/mL Important Information

INDICATION
KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.

The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS 
KYBELLA® is contraindicated in the presence of infection at the injection sites.

WARNINGS AND PRECAUTIONS
Marginal Mandibular Nerve Injury
Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.

Dysphagia
Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.

Injection-Site Hematoma/Bruising
In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.

Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures
To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.

Injection Site Alopecia
Cases of injection site alopecia have been reported with administration of KYBELLA®. Onset and duration may vary among individuals and may persist. Consider withholding subsequent treatments until resolution.

Injection Site Ulceration and Necrosis
Injections that are too superficial into the dermis may result in skin ulceration and necrosis. Cases of injection site ulceration and necrosis have been reported with administration of KYBELLA®. Do not administer KYBELLA® into affected area until complete resolution.

ADVERSE REACTIONS
The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.

Please see KYBELLA® full Prescribing Information.

*Individual results may vary.
Call Us Today! 661-257-8400

I'm Interested!

Please contact me with more information on this procedure.

©2018 DermaCure Valencia | Web Design by Small Dog Creative